Insufficient scRNA-seq data for expression of ZAR1 at single-cell level.
Insufficient scRNA-seq data for expression of ZAR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 50% | 7.48 | 1315 / 2642 | 4% | 0.08 | 31 / 705 |
| bladder | 33% | 2.14 | 7 / 21 | 3% | 0.04 | 14 / 504 |
| lung | 33% | 2.64 | 189 / 578 | 2% | 0.05 | 23 / 1155 |
| blood vessel | 34% | 4.44 | 448 / 1335 | 0% | 0 | 0 / 0 |
| skin | 20% | 4.52 | 368 / 1809 | 1% | 0.01 | 3 / 472 |
| intestine | 14% | 0.68 | 138 / 966 | 4% | 0.06 | 19 / 527 |
| stomach | 14% | 0.62 | 49 / 359 | 4% | 0.07 | 11 / 286 |
| ovary | 17% | 9.30 | 30 / 180 | 0% | 0 | 0 / 430 |
| thymus | 14% | 0.66 | 93 / 653 | 1% | 0.02 | 6 / 605 |
| uterus | 8% | 0.65 | 13 / 170 | 7% | 0.16 | 30 / 459 |
| prostate | 11% | 0.50 | 28 / 245 | 0% | 0.00 | 1 / 502 |
| esophagus | 4% | 0.18 | 60 / 1445 | 5% | 0.14 | 9 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.15 | 3 / 45 |
| adrenal gland | 4% | 0.17 | 10 / 258 | 3% | 0.04 | 6 / 230 |
| pancreas | 5% | 0.19 | 16 / 328 | 1% | 0.01 | 1 / 178 |
| kidney | 4% | 0.20 | 4 / 89 | 0% | 0 | 0 / 901 |
| adipose | 4% | 0.28 | 51 / 1204 | 0% | 0 | 0 / 0 |
| heart | 4% | 0.14 | 33 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 4% | 0.16 | 34 / 929 | 0% | 0 | 0 / 0 |
| breast | 3% | 0.12 | 13 / 459 | 0% | 0.00 | 2 / 1118 |
| spleen | 3% | 0.12 | 7 / 241 | 0% | 0 | 0 / 0 |
| muscle | 3% | 0.11 | 23 / 803 | 0% | 0 | 0 / 0 |
| liver | 1% | 0.04 | 3 / 226 | 0% | 0.01 | 1 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001556 | Biological process | oocyte maturation |
| GO_0006412 | Biological process | translation |
| GO_0140694 | Biological process | non-membrane-bounded organelle assembly |
| GO_0048255 | Biological process | mRNA stabilization |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
| GO_0140610 | Molecular function | RNA sequestering activity |
| GO_0003730 | Molecular function | mRNA 3'-UTR binding |
| GO_0140693 | Molecular function | molecular condensate scaffold activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZAR1 |
| Protein name | Zygote arrest 1 Zygote arrest protein 1 |
| Synonyms | |
| Description | FUNCTION: mRNA-binding protein that mediates formation of MARDO (mitochondria-associated ribonucleoprotein domain), a membraneless compartment that stores maternal mRNAs in oocytes. MARDO assembly around mitochondria is directed by an increase in mitochondrial membrane potential during oocyte growth. Promotes formation of MARDO phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to maternal mRNAs. Binds to the 3'-UTR of maternal mRNAs. Maternal mRNAs stored in the MARDO are translationally repressed. Essential for female fertility and oocyte-to-embryo transition by coordinating maternal mRNA storage, translation and degradation. . |
| Accessions | Q86SH2 ENST00000327939.4 B9EG67 |